Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease
暂无分享,去创建一个
M. Westphal | K. Pantel | S. Riethdorf | S. Loges | M. Glatzel | K. Lamszus | H. Wikman | S. Joosse | A. Hanssen | C. Bernreuther | C. Riebensahm | M. Mohme | L. Berger | J. Velthaus | C. Riebensahm
[1] S. Michiels,et al. EPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer. , 2019, Annals of Oncology.
[2] T. Tan,et al. Molecular characterization of breast cancer CTCs associated with brain metastasis , 2017, Nature Communications.
[3] K. Pantel,et al. Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape , 2017, Nature Reviews Clinical Oncology.
[4] J. Lee,et al. Local Consolidative Therapy versus Maintenance Therapy/Observation for Patients with Oligometastatic Non-Small Cell Lung Cancer without Progression after Front-Line Systemic Therapy: Results of a Multi-Institutional Phase II Randomized Study , 2016, The Lancet. Oncology.
[5] Henry Knipe,et al. Oligometastases , 2016, Radiopaedia.org.
[6] M. You,et al. Brain metastasis in lung cancer: Building a molecular and systems-level understanding to improve outcomes. , 2016, The international journal of biochemistry & cell biology.
[7] D. Atanackovic,et al. Characterization of different CTC subpopulations in non-small cell lung cancer , 2016, Scientific Reports.
[8] Hassan Lemjabbar-Alaoui,et al. Lung cancer: Biology and treatment options. , 2015, Biochimica et biophysica acta.
[9] K. Pantel,et al. Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer , 2015, Front. Oncol..
[10] Z. Ruan,et al. Patients with Single Brain Metastasis from Non-Small Cell Lung Cancer Equally Benefit from Stereotactic Radiosurgery and Surgery: A Systematic Review , 2015, Medical science monitor : international medical journal of experimental and clinical research.
[11] Klaus Pantel,et al. Biology, detection, and clinical implications of circulating tumor cells , 2014, EMBO molecular medicine.
[12] K. Hemminki,et al. Metastatic sites and survival in lung cancer. , 2014, Lung cancer.
[13] A. Iafrate,et al. Brain tumor cells in circulation are enriched for mesenchymal gene expression. , 2014, Cancer discovery.
[14] K. Pantel,et al. Challenges in circulating tumour cell research , 2014, Nature Reviews Cancer.
[15] M. Speicher,et al. Hematogenous dissemination of glioblastoma multiforme , 2014, Science Translational Medicine.
[16] T. Fehm,et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. , 2014, The Lancet. Oncology.
[17] K. Pantel,et al. Real-time liquid biopsy in cancer patients: fact or fiction? , 2013, Cancer research.
[18] G. Rodrigues,et al. Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature. , 2013, Lung cancer.
[19] C. Dive,et al. Clinical Utility of Circulating Tumour Cell Detection in Non-Small-Cell Lung Cancer , 2013, Current Treatment Options in Oncology.
[20] Tim Holland-Letz,et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay , 2013, Nature Biotechnology.
[21] Wei Yin,et al. The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis , 2013, Science Translational Medicine.
[22] R. Stahel,et al. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. , 2012, Lung cancer.
[23] S. Kusumoto,et al. Relationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancer. , 2012, Oncology research.
[24] G. Apolone,et al. Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience. , 2012, The Journal of thoracic and cardiovascular surgery.
[25] Caroline Dive,et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] O. Gires,et al. EpCAM and its potential role in tumor-initiating cells , 2012, Cell adhesion & migration.
[27] T. Molina,et al. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method , 2011, International journal of cancer.
[28] V. Valero,et al. Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells , 2011, International journal of cancer.
[29] Caroline Dive,et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Markus Munz,et al. The emerging role of EpCAM in cancer and stem cell signaling. , 2009, Cancer research.
[31] M. Loda,et al. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma , 2008, Cancer.
[32] K. Pienta,et al. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.
[33] Michael Morse,et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Brigitte Rack,et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.
[35] A. Puisieux,et al. Metastasis: a question of life or death , 2006, Nature Reviews Cancer.
[36] Alison Stopeck,et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Maria Werner-Wasik,et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.
[38] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[39] M. Riquet,et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. , 2001, Chest.
[40] Y Maruyama,et al. A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.
[41] P. Misir,et al. A Systematic Review of the Literature , 2019, HIV/AIDS and Adolescents.
[42] J. Izbicki,et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. , 2013, Clinical chemistry.
[43] R. Weichselbaum,et al. Oligometastases revisited , 2011, Nature Reviews Clinical Oncology.